Intérêt de la recherche du papillomavirus humain (HPV) dans le suivi post-conisation des CIN2–3

Soutter, 1997, Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia, Lancet, 349, 978, 10.1016/S0140-6736(96)08295-5 Baldauf, 1998, Cytology and Colposcopy after loop electrosurgical excision: implications for follow-up, Obstet Gynecol, 92, 124, 10.1016/S0029-7844(98)00144-6 Fahey, 1995, Meta analysis of Pap test accurancy, Am J Epidemiol, 141, 680, 10.1093/oxfordjournals.aje.a117485 Cuzick, 2006, Overview of the European and North American studies on HPV testing in primary cervical cancer screening, Int J Cancer, 119, 1095, 10.1002/ijc.21955 Paraskevaidis, 2001, Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia, Obstet Gynecol, 98, 833, 10.1016/S0029-7844(01)01535-6 Agence Nationale d’Accréditation et d’Évaluation en Santé. Conduite à tenir devant un frottis anormal du col de l’utérus. Paris 1998. www.has-sante.fr. Chua, 1997, Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri, Gynecol Oncol, 66, 108, 10.1006/gyno.1997.4753 Verguts, 2006, Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: The role of human papillomavirus testing and age at conisation, BJOG, 113, 1303, 10.1111/j.1471-0528.2006.01063.x Bosh, 1995, Prevalence of human papillomavirus in cervical cancer: A worldwide perspective, J Natl Cancer Int, 87, 796, 10.1093/jnci/87.11.796 Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Paraskevaidis, 2004, The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the litterature, Cancer Treat Rev, 30, 205, 10.1016/j.ctrv.2003.07.008 Zielinski, 2003, HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3, Gynecol Oncol, 91, 67, 10.1016/S0090-8258(03)00415-3 Zielinski, 2004, HPV testing and monitoring of women after treatment of CIN3: Review of the literature and meta-analysis, Obstet Gynecol Surv, 59, 543, 10.1097/00006254-200407000-00024 Nagai, 2000, Persistence of human papillomavirus infection after therapeutic conization for CIN3: is it an alarm for disease recurrence?, Gynecol Oncol, 79, 294, 10.1006/gyno.2000.5952 Lin, 2001, Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen, Am J Obstet Gynecol, 84, 940, 10.1067/mob.2001.112589 Jain, 2001, Negative predictive value of human papillomavirus test following conization of the cervix uteri, Gynecol Oncol, 82, 177, 10.1006/gyno.2001.6241 Elfgren, 2002, Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia, Obstet Gynecol, 100, 965, 10.1016/S0029-7844(02)02280-9 Cruickshank, 2002, Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia, BJOG, 109, 579, 10.1111/j.1471-0528.2002.01554.x Bodner, 2002, Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis, Anticancer Res, 22, 3733 Bekkers, 2002, The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia, Int J Cancer, 102, 148, 10.1002/ijc.10691 Acladious, 2002, Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN), Int J Cancer, 98, 435, 10.1002/ijc.10080 Houfflin Debarge, 2003, Value of HPV testing after conisation by loop electrosurgical excision for HGSIL, Gynecol Oncol, 90, 587, 10.1016/S0090-8258(03)00372-X Bar-Am, 2003, Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up, Gynecol Oncol, 91, 149, 10.1016/S0090-8258(03)00435-9 Sarian, 2004, HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia, Gynecol Oncol, 94, 181, 10.1016/j.ygyno.2004.03.036 Cecchini, 2004, Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure, Tumori, 90, 225, 10.1177/030089160409000211 Hernadi, 2005, Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions, Eur J Obstet Gynecol Reprod Biol, 118, 229, 10.1016/j.ejogrb.2004.06.029 Kreimer, 2006, Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease, Cancer Epidemiol Biomarkers Prev, 15, 908, 10.1158/1055-9965.EPI-05-0845 Alonso, 2006, Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN2–3, Gynecol Oncol, 103, 631, 10.1016/j.ygyno.2006.04.016 Prétet, 2004, High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women, J Clin Virol, 31, 140, 10.1016/j.jcv.2004.02.008 Murdoch, 1992, Histological incomplete excision of CINafter large loop excision of the transformation zone (LLETZ) merits careful follow up, no retreatment, Br J Obstet Gynaecol, 99, 930, 10.1111/j.1471-0528.1992.tb13704.x Bigrigg, 1994, Efficacy and safety of large-loop excision of the transformation zone, Lancet, 343, 32, 10.1016/S0140-6736(94)90881-8 Ronco, 2006, Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial, J Natl Cancer Inst, 98, 765, 10.1093/jnci/djj209 Reich, 2001, Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins, Obstet Gynecol, 97, 428, 10.1016/S0029-7844(00)01174-1 Reich, 2002, Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins, Obstet Gynecol, 99, 193, 10.1016/S0029-7844(01)01683-0 Murta, 1999, Importance of surgical margins in conization for CIN III, Arch Gynecol Obstet, 263, 42, 10.1007/s004040050260 Huang, 1998, Positive margins after cervical conization as an indicator of residual dysplasia, Prim Care Update Ob Gyn, 5, 160, 10.1016/S1068-607X(98)00054-7 Bretelle, 2000, Conisation non in sano : quelle attitude adopter ?, Ann Chir, 125, 444, 10.1016/S0003-3944(00)00219-4 Sarian, 2004, Factors associated with HPV persistence after treatment for high-grade cervical intraepithelial neoplasia with large loop excision of the transformation zone (LLETZ), J Clin Virol, 31, 270, 10.1016/j.jcv.2004.05.012 Ho, 1995, Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia, J Natl Cancer Inst, 87, 1365, 10.1093/jnci/87.18.1365 Remmink, 1995, The presence of persistent high-risk HPV genotype in dysplasic cervical lesions is associated with progressive disease: natural history up to 36 months, Int J Cancer, 61, 306, 10.1002/ijc.2910610305 Nobbenhuis, 1999, Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study, Lancet, 354, 20, 10.1016/S0140-6736(98)12490-X zur Hausen, 2000, Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis, J Natl Cancer Inst, 92, 690, 10.1093/jnci/92.9.690 Clavel, 1999, Hydrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women, Br J Cancer, 80, 1306, 10.1038/sj.bjc.6690523 Syrjanen, 2005, Clearance of high-risk HPV DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study), Eur J Obstet Gynecol Reprod Biol, 19, 219, 10.1016/j.ejogrb.2004.07.036 Elfgren, 1996, Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against HPV antigens, Am J Obstet Gynecol, 174, 937, 10.1016/S0002-9378(96)70330-7 Nobbenhuis, 2001, Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia, Br J Cancer, 84, 796, 10.1054/bjoc.2000.1689 Kyrgiou, 2006, Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis, Lancet, 367, 489, 10.1016/S0140-6736(06)68181-6